230 related articles for article (PubMed ID: 31463822)
1. Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results.
Marino MA; Pinker K; Leithner D; Sung J; Avendano D; Morris EA; Jochelson M
Mol Imaging Biol; 2020 Jun; 22(3):780-787. PubMed ID: 31463822
[TBL] [Abstract][Full Text] [Related]
2. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
3. Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Leithner D; Horvat JV; Marino MA; Bernard-Davila B; Jochelson MS; Ochoa-Albiztegui RE; Martinez DF; Morris EA; Thakur S; Pinker K
Breast Cancer Res; 2019 Sep; 21(1):106. PubMed ID: 31514736
[TBL] [Abstract][Full Text] [Related]
4. Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging.
Marino MA; Leithner D; Sung J; Avendano D; Morris EA; Pinker K; Jochelson MS
Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32708512
[TBL] [Abstract][Full Text] [Related]
5. A multicentric study of radiomics and artificial intelligence analysis on contrast-enhanced mammography to identify different histotypes of breast cancer.
Petrillo A; Fusco R; Petrosino T; Vallone P; Granata V; Rubulotta MR; Pariante P; Raiano N; Scognamiglio G; Fanizzi A; Massafra R; Lafranceschina M; La Forgia D; Greco L; Ferranti FR; De Soccio V; Vidiri A; Botta F; Dominelli V; Cassano E; Sorgente E; Pecori B; Cerciello V; Boldrini L
Radiol Med; 2024 Jun; 129(6):864-878. PubMed ID: 38755477
[TBL] [Abstract][Full Text] [Related]
6. [The value of CT radiomics in the prediction of EGFR mutation in lung cancer].
Yu YX; Wang XM; Shi C; Hu S; Hu CH
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):690-695. PubMed ID: 32187913
[No Abstract] [Full Text] [Related]
7. Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer.
Ge S; Yixing Y; Jia D; Ling Y
BMC Med Imaging; 2022 Sep; 22(1):166. PubMed ID: 36104679
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.
Ni M; Zhou X; Liu J; Yu H; Gao Y; Zhang X; Li Z
BMC Cancer; 2020 Nov; 20(1):1073. PubMed ID: 33167903
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.
Ma W; Zhao Y; Ji Y; Guo X; Jian X; Liu P; Wu S
Acad Radiol; 2019 Feb; 26(2):196-201. PubMed ID: 29526548
[TBL] [Abstract][Full Text] [Related]
12. Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer.
Qian N; Jiang W; Wu X; Zhang N; Yu H; Guo Y
Comput Methods Programs Biomed; 2024 Jun; 250():108194. PubMed ID: 38678959
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of MRI Radiomics Models to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer.
Peng Y; Zhang X; Qiu Y; Li B; Yang Z; Huang J; Lin J; Zheng C; Hu L; Shen J
AJR Am J Roentgenol; 2024 Apr; 222(4):e2330603. PubMed ID: 38265001
[No Abstract] [Full Text] [Related]
14. HER2-positive breast cancer patients: correlation between mammographic and pathological findings.
Radenkovic S; Konjevic G; Isakovic A; Stevanovic P; Gopcevic K; Jurisic V
Radiat Prot Dosimetry; 2014 Nov; 162(1-2):125-8. PubMed ID: 25063784
[TBL] [Abstract][Full Text] [Related]
15. Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis.
Son J; Lee SE; Kim EK; Kim S
Sci Rep; 2020 Dec; 10(1):21566. PubMed ID: 33299040
[TBL] [Abstract][Full Text] [Related]
16. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer.
Zhang HX; Sun ZQ; Cheng YG; Mao GQ
J Xray Sci Technol; 2019; 27(3):485-492. PubMed ID: 31081797
[TBL] [Abstract][Full Text] [Related]
18. MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study.
Song SE; Bae MS; Chang JM; Cho N; Ryu HS; Moon WK
Acta Radiol; 2017 Jul; 58(7):792-799. PubMed ID: 27754920
[TBL] [Abstract][Full Text] [Related]
19. The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer.
You C; Li J; Zhi W; Chen Y; Yang W; Gu Y; Peng W
J Transl Med; 2019 Jul; 17(1):182. PubMed ID: 31262334
[TBL] [Abstract][Full Text] [Related]
20. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
